Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment

Completed · Phase 1

Conditions studied: Hepatic Impairment

In brief

Hepatic impairment PK study

Key facts

Study ID

NCT03309202

Run by

Pfizer

People needed

24

Starts

2017-12-19

Expected to finish

2018-07-18

Last updated by the study team

2019-08-08

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• Orlando Clinical Research Center — Orlando, Florida, United States
• Pfizer Clinical Research Unit — Brussels, Belgium
• Pharmaceutical Research Associates CZ, s.r.o. — Prague, Czechia
• Nemocnice Na Bulovce — Prague, Czechia
• Summit Clinical Research s.r.o. — Bratislava, Slovakia
• Univerzitná Nemocnica Bratislava — Bratislava, Slovakia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.